glpg.com (GLPG) Company Sales Revenue

glpg.com - graphic logo of issuer GLPG

Galapagos NV is transforming its approach to cell therapies, overcoming R&D complexities and reliance on partners. The company's sales volatility on GURU.Markets captures cash flow dynamics, where the 1.28 mark records this indicator. While geopolitical tensions hinder global drug trials, substantial capital allows the firm to develop its oncology portfolio independently of economic cycles.

GLPG Galapagos Genomics Revenue and Sales Volume (07/04/2022 - 05/08/2026)

Comprehensive metric breakdowns and analytics for Galapagos N.V. (GLPG)

- market price and analyst price targets:
Comprehensive company analysis:Galapagos NV (GLPG)
Brand item of Galapagos

To minimize investment risks, it is necessary to track product sales dynamics, which record daily revenue and the fulfillment of commercial plans through the company's total sales. For the biopharmaceutical leader Galapagos NV (GLPG), which invests in cell therapy and small molecules, steady growth of this indicator confirms market demand for innovation and the fundamental resilience of the business.

Key competitors

HLN: Company Sales Revenue|Company Revenue Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Company Sales Revenue|Company Revenue Jyong Biotech MENS|Ligand Pharma - Company Revenue|AMRX - Company Revenue|Company Total Revenue perrigo.com|ALVO (Alvotech SA) - Company Sales|Company Total Sales Volume Liquidia Technologies LQDA|Company Sales ANIP|Company Sales Volume MNKD (Afrezza)|Revenue and Sales Volume AMPH|PCRX (Pacira BioSciences) - Company Sales Revenue|Revenue and Sales Volume SPRY (ARS Pharmaceuticals, Inc.)|Theravance Biopharma, Inc. - Company Revenue|Aquestive Corp - Revenue and Sales Volume|scpharmaceuticals.com (SCPH) - Company Sales|TECX: Revenue and Sales Volume|Tonix Pharmaceuticals - Company Sales Revenue|Company Sales SXTC|EPRX: Company Sales Revenue|Company Sales BHST (BioHarvest Sciences Inc.)|Company Gross Revenue Invizyne|Company Revenue Oramed Pharmaceuticals ORMP|Company Sales Revenue ENTX|HYFT - Company Revenue|Company Sales Revenue ABVC (ABVC BioPharma Inc.)|CPIX: Revenue and Sales Volume|Quantum BioPharma Limited - Company Sales Revenue|FGEN (FibroGen Corp) - Revenue and Sales Volume|Revenue and Sales Volume Telomir Pharmaceuticals|Revenue and Sales Volume RANI|SNYR (Synergy CHC Corp.) - Company Sales Revenue|Revenue and Sales Volume RLYB (Rallybio Corp)|LEXX: Company Sales Volume|PULM - Company Revenue|PTHL: Company Revenue|APM (aptorumgroup.com) - Company Sales|Lyra Therapeutics - Company Sales Revenue|Company Revenue Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Company Gross Revenue|Revenue and Sales Volume YCBD|PRFX: Company Annual Revenue|Company Revenue altamiratherapeutics.com CYTO|Revenue and Sales Volume Lipella Pharmaceuticals Inc LIPO|OPTN - Company Revenue|Company Gross Revenue Pieris Pharma PIRS|Procaps Group SA (PROC) - Company Revenue|Company Annual Revenue PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Revenue and Sales Volume|SLRN: Company Sales Revenue|Revenue and Sales Volume TFFP